Emerald Mutual Fund Advisers Trust Has Cut Its Adamas Pharmaceuticals (ADMS) Position; 1 Analysts Covering eServGlobal Limited (LON:ESG)

February 21, 2018 - By Henry Gaston

Emerald Mutual Fund Advisers Trust decreased Adamas Pharmaceuticals Inc (ADMS) stake by 7.32% reported in 2017Q3 SEC filing. Emerald Mutual Fund Advisers Trust sold 41,852 shares as Adamas Pharmaceuticals Inc (ADMS)’s stock declined 13.31%. The Emerald Mutual Fund Advisers Trust holds 529,937 shares with $11.22M value, down from 571,789 last quarter. Adamas Pharmaceuticals Inc now has $705.97 million valuation. The stock increased 2.24% or $0.59 during the last trading session, reaching $26.98. About 28,160 shares traded. Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) has declined 0.40% since February 21, 2017 and is downtrending. It has underperformed by 17.10% the S&P500.

Among 2 analysts covering eServGlobal Ltd (LON:ESG), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. eServGlobal Ltd had 19 analyst reports since October 5, 2015 according to SRatingsIntel. The company was maintained on Wednesday, January 24 by FinnCap. The stock of eServGlobal Limited (LON:ESG) earned “Corporate” rating by FinnCap on Monday, March 27. The firm has “Corporate” rating by FinnCap given on Monday, November 21. The firm has “Corporate” rating by FinnCap given on Thursday, November 9. The stock has “Buy” rating by Canaccord Genuity on Monday, October 5. FinnCap maintained eServGlobal Limited (LON:ESG) rating on Tuesday, September 13. FinnCap has “Corporate” rating and GBX 10 target. FinnCap maintained eServGlobal Limited (LON:ESG) rating on Wednesday, September 28. FinnCap has “Corporate” rating and GBX 10 target. The firm has “Corporate” rating given on Monday, August 15 by FinnCap. The rating was maintained by FinnCap on Thursday, June 29 with “Corporate”. The stock of eServGlobal Limited (LON:ESG) has “Corporate” rating given on Thursday, September 22 by FinnCap. See eServGlobal Limited (LON:ESG) latest ratings:




24/01/2018 Broker: FinnCap Rating: Corporate Old Target: GBX 20.00 New Target: GBX 20.00 Maintain
19/12/2017 Broker: FinnCap Rating: Corporate Old Target: GBX 20.00 New Target: GBX 20.00 Maintain
09/11/2017 Broker: FinnCap Rating: Corporate Old Target: GBX 20.00 New Target: GBX 20.00 Maintain
20/10/2017 Broker: FinnCap Rating: Corporate Old Target: GBX 18.00 New Target: GBX 20.00 Maintain
02/10/2017 Broker: FinnCap Rating: Corporate Old Target: GBX 10.00 New Target: GBX 18.00 Maintain

eServGlobal Limited provides telecommunications software solutions to mobile and financial service providers in the Middle East, the Asia Pacific, Europe, Africa, and Central and South America. The company has market cap of 93.85 million GBP. It offers mobile money solutions, including mobile financial services, mobile wallet, mobile commerce, recharge, analytics, promotions, and agent management, as well as remittance solutions; and interactive voice response solutions. It currently has negative earnings.

The stock decreased 2.06% or GBX 0.2 during the last trading session, reaching GBX 9.5. About 52,000 shares traded. eServGlobal Limited (LON:ESG) has 0.00% since February 21, 2017 and is . It has underperformed by 16.70% the S&P500.

Analysts await Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) to report earnings on February, 22 after the close. They expect $-1.15 EPS, down 69.12% or $0.47 from last year’s $-0.68 per share. After $-1.04 actual EPS reported by Adamas Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 10.58% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: